Cargando…

Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis

Objective: The aims of this study were to investigate the incidence, risk factors and prognosis of pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery (GKRS). Methods and materials: Between December 1993 and December 2016, 751 consecutive pituitary adenoma patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Junyi, Li, Yanli, Wu, Lisha, Yang, Xin, Quan, Tingting, Li, Xi, Zeng, Jiamin, Deng, Yinhui, Yu, Jinxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847656/
https://www.ncbi.nlm.nih.gov/pubmed/33531981
http://dx.doi.org/10.7150/jca.52349
_version_ 1783644967332216832
author Fu, Junyi
Li, Yanli
Wu, Lisha
Yang, Xin
Quan, Tingting
Li, Xi
Zeng, Jiamin
Deng, Yinhui
Yu, Jinxiu
author_facet Fu, Junyi
Li, Yanli
Wu, Lisha
Yang, Xin
Quan, Tingting
Li, Xi
Zeng, Jiamin
Deng, Yinhui
Yu, Jinxiu
author_sort Fu, Junyi
collection PubMed
description Objective: The aims of this study were to investigate the incidence, risk factors and prognosis of pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery (GKRS). Methods and materials: Between December 1993 and December 2016, 751 consecutive pituitary adenoma patients treated with GKRS were retrospectively reviewed in a single center. There were 271 male (36.1%) and 480 female (63.9%) patients with a median age of 38.5 (range, 7.2-84.0) years. The number of nonfunctioning pituitary adenomas (NFPAs) and functioning pituitary adenomas were 369 (49.1%) and 382 (50.9%) respectively. The median follow-up time was 61.1 (range, 12.1-304.4) months. Results: In this study, 88 patients (11.7%) were diagnosed with pituitary hemorrhage before GKRS, 55 patients (7.3%) developed new or worsened pituitary hemorrhage after GKRS (excluding 3 patients with new or worsened pituitary hemorrhage due to tumor regrowth). The median time to new or worsened pituitary hemorrhage after GKRS was 18.9 (range 3.1-70.7) months. Overall, 128 patients (17.0%) were diagnosed with pituitary hemorrhage in the entire series. After adjustment with logistic regression, nonfunctioning pituitary adenomas (NFPAs) (odds ratio [OR]=2.121, 95% confidence interval [CI]=1.195-3.763, p=0.010) and suprasellar extension (OR=2.470, 95% CI=1.361-4.482, p=0.003) were associated with pituitary hemorrhage before GKRS. NFPA (OR=3.271, 95% CI=1.278-8.373, p=0.013) was associated with new or worsened pituitary hemorrhage after GKRS. Five patients received surgical resection for new or worsened pituitary hemorrhage were considered as GKRS treatment failure. Two patients with new hypopituitarism were considered to be owed to new or worsened pituitary hemorrhage after GKRS. Conclusions: New or worsened pituitary hemorrhage after GKRS was not an uncommon phenomenon. NFPA was an independent risk factor of new or worsened pituitary hemorrhage after GKRS. New or worsened pituitary hemorrhage after GKRS could lead to GKRS treatment failure. GKRS might be a precipitating factor of pituitary hemorrhage.
format Online
Article
Text
id pubmed-7847656
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-78476562021-02-01 Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis Fu, Junyi Li, Yanli Wu, Lisha Yang, Xin Quan, Tingting Li, Xi Zeng, Jiamin Deng, Yinhui Yu, Jinxiu J Cancer Research Paper Objective: The aims of this study were to investigate the incidence, risk factors and prognosis of pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery (GKRS). Methods and materials: Between December 1993 and December 2016, 751 consecutive pituitary adenoma patients treated with GKRS were retrospectively reviewed in a single center. There were 271 male (36.1%) and 480 female (63.9%) patients with a median age of 38.5 (range, 7.2-84.0) years. The number of nonfunctioning pituitary adenomas (NFPAs) and functioning pituitary adenomas were 369 (49.1%) and 382 (50.9%) respectively. The median follow-up time was 61.1 (range, 12.1-304.4) months. Results: In this study, 88 patients (11.7%) were diagnosed with pituitary hemorrhage before GKRS, 55 patients (7.3%) developed new or worsened pituitary hemorrhage after GKRS (excluding 3 patients with new or worsened pituitary hemorrhage due to tumor regrowth). The median time to new or worsened pituitary hemorrhage after GKRS was 18.9 (range 3.1-70.7) months. Overall, 128 patients (17.0%) were diagnosed with pituitary hemorrhage in the entire series. After adjustment with logistic regression, nonfunctioning pituitary adenomas (NFPAs) (odds ratio [OR]=2.121, 95% confidence interval [CI]=1.195-3.763, p=0.010) and suprasellar extension (OR=2.470, 95% CI=1.361-4.482, p=0.003) were associated with pituitary hemorrhage before GKRS. NFPA (OR=3.271, 95% CI=1.278-8.373, p=0.013) was associated with new or worsened pituitary hemorrhage after GKRS. Five patients received surgical resection for new or worsened pituitary hemorrhage were considered as GKRS treatment failure. Two patients with new hypopituitarism were considered to be owed to new or worsened pituitary hemorrhage after GKRS. Conclusions: New or worsened pituitary hemorrhage after GKRS was not an uncommon phenomenon. NFPA was an independent risk factor of new or worsened pituitary hemorrhage after GKRS. New or worsened pituitary hemorrhage after GKRS could lead to GKRS treatment failure. GKRS might be a precipitating factor of pituitary hemorrhage. Ivyspring International Publisher 2021-01-01 /pmc/articles/PMC7847656/ /pubmed/33531981 http://dx.doi.org/10.7150/jca.52349 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Fu, Junyi
Li, Yanli
Wu, Lisha
Yang, Xin
Quan, Tingting
Li, Xi
Zeng, Jiamin
Deng, Yinhui
Yu, Jinxiu
Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
title Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
title_full Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
title_fullStr Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
title_full_unstemmed Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
title_short Pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
title_sort pituitary hemorrhage in pituitary adenomas treated with gamma knife radiosurgery: incidence, risk factors and prognosis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847656/
https://www.ncbi.nlm.nih.gov/pubmed/33531981
http://dx.doi.org/10.7150/jca.52349
work_keys_str_mv AT fujunyi pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT liyanli pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT wulisha pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT yangxin pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT quantingting pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT lixi pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT zengjiamin pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT dengyinhui pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis
AT yujinxiu pituitaryhemorrhageinpituitaryadenomastreatedwithgammakniferadiosurgeryincidenceriskfactorsandprognosis